MGX vs TFX · rev $25.2M vs P/E 2083, rev $1.12B
Metagenomi, Inc. Common Stock (MGX) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Metagenomi, Inc. Common Stock (MGX) is a biotechnology company listed on NASDAQ.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported MGX revenue for 2025-12-31 was $25.2M. Net income was -$87.9M. Revenue was down 51.8% from 2024-12-31 to 2025-12-31. MGX currently screens at market cap $44.4M.
Latest reported TFX revenue for 2026-06-30 was $1.12B. Net income was $91.5M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
MGX currently screens at market cap $44.4M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the MGX and TFX stock pages for the full models.
Not investment advice.